Long-Term Safety of Elagolix With Hormonal Add-Back Therapy in Women With Endometriosis-Associated Pain: 24-Month Results

被引：0
|
作者：
Simon, James [1 ]
Kim, Jin Hee [1 ]
Thomas, James [1 ]
Miller, Paul [1 ]
Snabes, Michael [1 ]
机构：
[1] IntimMedicine Specialists, Washington, DC USA
来源：
OBSTETRICS AND GYNECOLOGY | 2022年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
A86
引用
收藏
页码：25S / 26S
页数：2
相关论文
共 50 条
  • [41] THE IMPACT OF ELAGOLIX ON QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED STUDIES USING THE ENDOMETRIOSIS HEALTH PROFILE QUESTIONNAIRE.
    Taylor, H. S.
    Surrey, E.
    Soliman, A. M.
    Castelli-Haley, J.
    Rowan, J. P.
    Chwalisz, K.
    Thomas, J. W.
    Schwefel, B.
    Williams, L. A.
    Jain, R. I.
    FERTILITY AND STERILITY, 2016, 106 (03) : E93 - E93
  • [42] TIME TO MINIMAL OR NO PELVIC PAIN WITH RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM THE SPIRIT PROGRAM.
    As-Sanie, Sawsan
    Johnson, Neil
    Lukes, Andrea S.
    Ferreira, Juan Camilo Arjona
    Li, Juliet
    Perry, Julie Stein
    Wagman, Rachel B.
    Giudice, Linda C.
    FERTILITY AND STERILITY, 2022, 118 (04) : E6 - E7
  • [43] Personality Profiles Associated with Long-Term Success in Bariatric Surgery: 24-Month Follow-Up
    Montorio, Ignacio
    Izal, Maria
    Bellot, Ana
    Rodriguez, Javier
    de Iceta, Mariano
    BEHAVIORAL SCIENCES, 2023, 13 (10)
  • [44] LINZAGOLIX MAY ADDRESS THE LONG-TERM TREATMENT NEEDS OF WOMEN WITH UTERINE FIBROIDS (UF) WHO HAVE CONTRAINDICATIONS TO HORMONAL ADD-BACK THERAPY (ABT): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS.
    Bradley, Linda D.
    Marsh, Erica E.
    Garner, Elizabeth
    FERTILITY AND STERILITY, 2020, 114 (03) : E522 - E522
  • [45] Long-term metabolic safety after a switch from clozapine to zotepine in refractory schizophrenia: a 24-month study
    Lin, C. C.
    Chen, J. Y.
    Bai, Y. M.
    Wang, Y. C.
    Liou, Y. J.
    Chen, Z. T.
    Lin, W. K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S449 - S449
  • [46] INTERIM. RESULTS OF A PHASE 3B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING 24-MONTH SAFETY OF ELACOLIX WITH ADD-BACK FOR HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
    Poindexter, Yvette M.
    Ng, Juki W.
    Brown, Eric L.
    Rodriguez, Jose
    Bredeson, Liesl K.
    McIlroy, Brenda Hinman
    La, Hong
    Snabes, Michael C.
    FERTILITY AND STERILITY, 2022, 118 (04) : E50 - E51
  • [47] Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data
    As-Sanie, S.
    Giudice, L.
    Abrao, M. S.
    Wilk, K.
    Mehedintu, C.
    Becker, C.
    Ferreira, J. C. Arjona
    Wagman, R. B.
    Wang, F.
    Warsi, Q. A.
    Neil, J.
    HUMAN REPRODUCTION, 2021, 36 : 57 - 58
  • [48] Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies (vol 132, pg 147, 2018)
    Surrey, E.
    Taylor, H. S.
    Giudice, L.
    Lessey, B. A.
    Abrao, M. S.
    Archer, D. F.
    OBSTETRICS AND GYNECOLOGY, 2018, 132 (06): : 1507 - 1508
  • [49] EVALUATION OF THE EFFECT OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY (BMD) OVER TWO YEARS IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: SPIRIT LONG-TERM EXTENSION (LTE) STUDY
    Johnson, Neil
    Ferrari, Serge L.
    Wang, Furong
    Perry, Julie Stein
    Wagman, Rachel B.
    McClung, Michael R.
    FERTILITY AND STERILITY, 2022, 118 (04) : E223 - E223
  • [50] Durability and long-term safety of Enteryx® implantation for GERD:: 24-month follow-up of a prospective multicenter trial
    Johnson, DA
    Aisenberg, J
    Cohen, LB
    Foley, TR
    Ganz, RA
    Lehman, GA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S296 - S296
12345